Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Mylan Products Ltd, 20 Station Close, Potters Bar, Herts, EN6 1TL, UK
Physiotens Tablets 200 micrograms.
| Pharmaceutical Form |
|---|
|
Film coated tablets. Light pink, round, biconvex, film-coated tablets imprinted ‘0.2’ on one face. |
Each tablet contains 200 micrograms moxonidine.
Excipients:
95.8 mg lactose per tablet.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Moxonidine |
Moxonidine has been shown to bind selectively to the I1-imidazoline receptors in the brain stem. These imidazoline-sensitive receptors are concentrated in the rostral ventrolateral medulla, an area which is of crucial importance for central control of the peripheral sympathetic nervous system. The result of this effect on the I1-imidazoline receptors has been apparent in reduced activity in the sympathetic nerves. (demonstrated for cardiac, splanchnic and renal sympathetic nerves). |
| List of Excipients |
|---|
|
Lactose |
The tablets are packed in blister strips made of PVC/PVdC or PVC film with covering Aluminium foil, within cartons. Each carton contains 14, 28 or 84 tablets.
Not all pack sizes may be marketed.
Mylan Products Ltd, 20 Station Close, Potters Bar, Herts, EN6 1TL, UK
PL 46302/0045
15/09/1997
| Drug | Countries | |
|---|---|---|
| PHYSIOTENS | Australia, Cyprus, Germany, Estonia, Finland, France, Croatia, Lithuania, Malta, Poland, Romania, Tunisia, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
